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Atypical APC/C-dependent degradation of Mcl-1
provides an apoptotic timer during mitotic arrest
Lindsey A Allan1,†, Agnieszka Skowyra1,†, Katie I Rogers1, Désirée Zeller1 & Paul R Clarke1,2,*
Abstract
The initiation of apoptosis in response to the disruption of mitosis
provides surveillance against chromosome instability. Here, we
show that proteolytic destruction of the key regulator Mcl-1
during an extended mitosis requires the anaphase-promoting
complex or cyclosome (APC/C) and is independent of another ubiq-
uitin E3 ligase, SCFFbw7. Using live-cell imaging, we show that the
loss of Mcl-1 during mitosis is dependent on a D box motif found
in other APC/C substrates, while an isoleucine-arginine (IR) C-term-
inal tail regulates the manner in which Mcl-1 engages with the
APC/C, converting Mcl-1 from a Cdc20-dependent and checkpoint-
controlled substrate to one that is degraded independently of
checkpoint strength. This mechanism ensures a relatively slow but
steady rate of Mcl-1 degradation during mitosis and avoids its
catastrophic destruction when the mitotic checkpoint is satisfied,
providing an apoptotic timer that can distinguish a prolonged
mitotic delay from normal mitosis. Importantly, we also show that
inhibition of Cdc20 promotes mitotic cell death more effectively
than loss of APC/C activity through differential effects on Mcl-1
degradation, providing an improved strategy to kill cancer cells.
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Introduction
Cellular responses to the disruption of mitosis include the induction
of cell death by apoptosis, which normally prevents the propagation
of chromosomal abnormalities that result from defects in mitotic
spindle assembly. Identification of the mechanisms controlling the
induction of apoptosis during mitosis is not only important to
understand how chromosome instability is generated in cancer, but
also how cells respond to anti-cancer chemotherapeutics such as
microtubule poisons that target the spindle and cause an arrest or
prolonged delay in mitosis.
The timing of exit from mitosis is determined by the mitotic or
spindle assembly checkpoint. During prometaphase, kinetochores
that are unattached to spindle microtubules signal through the
Mps1-dependent generation of the mitotic checkpoint complex
(MCC), which inhibits the Cdc20-dependent activation of the
anaphase-promoting complex or cyclosome (APC/C), an E3 ligase
that ubiquitinates key substrates and targets them for destruction by
the proteasome (Pines, 2011; Sivakumar & Gorbsky, 2015). If the
proper bi-allelic attachment of microtubules to kinetochores fails or
is prevented pharmacologically, for instance by a drug that disrupts
microtubule dynamics, then a cell is held in mitosis for a prolonged
period by sustained activation of the checkpoint.
A key substrate of APC/CCdc20 is cyclin B1, the regulatory
subunit of the CDK1-cyclin B1 protein kinase that acts as the master
regulator of mitosis. During a prolonged mitotic arrest, the loss of
cyclin B1 is restrained, although it eventually drops below the
threshold required to maintain the arrest despite the checkpoint
(Brito & Rieder, 2006). The propensity of cells to undergo apoptosis
correlates with the duration of mitosis (Bekier et al, 2009; Huang
et al, 2009; Colin et al, 2015), which indicates a progressive
increase in pro-apoptotic signalling until it reaches a threshold suffi-
cient to initiate cell death. Whether or not a cell dies in mitosis
depends upon whether the apoptotic threshold is breached before
exit from mitosis (Gascoigne & Taylor, 2008). Entry into interphase
is generally associated with increased cell survival, probably due to
a raised apoptotic threshold, although cells that have been arrested
for a prolonged period in mitosis can subsequently undergo cell
cycle arrest or post-mitotic cell death (Bekier et al, 2009; Huang
et al, 2009; Uetake & Sluder, 2010; Colin et al, 2015).
Mcl-1 has emerged as a major determinant of the cellular
response to microtubule poisons that target mitotic cells (Harley
et al, 2010; Shi et al, 2011; Wertz et al, 2011; Dikovskaya et al,
2015; Haschka et al, 2015; Topham et al, 2015; Sloss et al, 2016).
Mcl-1 is a member of the anti-apoptotic Bcl-2 family of proteins that
suppress the activation of caspases, which are apoptotic proteases
that bring about cellular destruction (Budihardjo et al, 1999). Antag-
onism of anti-apoptotic Bcl-2 family proteins, which are often over-
expressed in tumours, has been proposed as a valuable anti-cancer
strategy (Opferman, 2016). Importantly, Mcl-1 is degraded by an
ubiquitin-proteasome-dependent mechanism in response to the
disruption of mitosis (Harley et al, 2010; Wertz et al, 2011).
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Removal of Mcl-1 promotes mitotic cell death while stabilisation of
the protein inhibits apoptosis induced by mitotic arrest (Colin et al,
2015; Topham et al, 2015; Sloss et al, 2016). In addition, Mcl-1
controls cell fate through suppression of both caspase-dependent
activation of DNA damage signalling at telomeres during a
prolonged mitosis and the subsequent activation of p53 in cells that
initially survive mitotic arrest and enter interphase (Colin et al,
2015; Hain et al, 2016). Mcl-1 is therefore a key modulator of effects
of mitotic disruption, and the mechanisms that determine Mcl-1
instability during mitotic arrest are crucial to understand cellular
responses to anti-mitotic drugs.
The ubiquitin E3 ligase that catalyses the poly-ubiquitylation of
Mcl-1 and primes it for proteasomal destruction during mitosis is
therefore of significant interest. Previous biochemical experiments
have suggested roles for SCFFbw7 (Wertz et al, 2011) and APC/
CCdc20 (Harley et al, 2010) in the control of Mcl-1 stability during
mitosis, although Fbw7 might have an indirect role through control
of the progression of mitosis (Finkin et al, 2008) and the require-
ment for Cdc20 for mitotic Mcl-1 destruction has been questioned
(Dı´az-Martı´nez et al, 2014; Sloss et al, 2016). In this report, we
establish by live-cell imaging that the loss of Mcl-1 during mitotic
arrest requires APC/C and not SCFFbw7. We show that Mcl-1 is an
atypical APC/C substrate with an unusual dependency on Cdc20. A
C-terminal isoleucine-arginine (IR) motif makes recognition of Mcl-1
by APC/C insensitive to the level of Cdc20. This mechanism ensures
that Mcl-1 is degraded during a prolonged mitosis at a relatively
slow rate that is not controlled by the spindle assembly checkpoint.
Mcl-1 destruction is not accelerated when the checkpoint is relieved,
preventing catastrophic apoptosis as a cell progresses out of mitosis.
We propose that the steady rate of Mcl-1 loss during mitotic arrest
enables it to act as a timer that measures the period of mitotic arrest
independently of checkpoint strength and thereby distinguishes
severe mitotic disruption from the normal progression of mitosis.
Consistent with an atypical mechanism of APC/C-mediated Mcl-1
destruction, we show that distinct means of inducing mitotic arrest
have differential effects on Mcl-1 degradation compared to that of
cyclin B1, yielding alternative cell fate profiles. These properties
provide opportunities to enhance cell killing in response to
chemotherapeutic drugs that target mitotic cells, particularly in
cancer cells that are prone to mitotic slippage. Thus, we show that
the propensity to undergo mitotic cell death is determined by both
the temporal period of mitosis and the nature of the mitotic arrest.
Results
Mcl-1 is targeted for degradation during mitotic arrest by APC/C
Previous work has identified two ubiquitin E3 ligases, namely APC/
C and SCFFbw7, as determinants of Mcl-1 loss in response to micro-
tubule poisons (Harley et al, 2010; Wertz et al, 2011). To test the
relative contributions of these enzymes to Mcl-1 degradation specifi-
cally during mitotic arrest, we analysed by Western blotting the
requirement for each E3 ligase in pools of isolated rounded-up
mitotic cells synchronised in the period of mitotic arrest by
treatment with the microtubule poison nocodazole (830 nM).
siRNA-mediated knockdown of APC11, a catalytic subunit of APC/
C, stabilised Mcl-1 in HeLa cells during a synchronised mitotic arrest
(Fig 1A). Although knockdown of Fbw7 (encoded by the FBXW7
gene and also known as hCDC4; Davis et al, 2014) elevated Mcl-1
protein levels in interphase, it did not prevent Mcl-1 degradation
during mitotic arrest (Fig 1A). While Mcl-1 degradation did appear
to be slightly reduced in DLD1 FBW7/ knockout cells treated with
100 nM paclitaxel (Fig EV1A and B), the mitotic arrest in these cells
was compromised compared with wild-type cells as demonstrated
by lower levels of both MPM2 and phosphorylated APC3 and by the
reduced number of cells positive for histone-H3 phosphorylated on
Ser10 (p-Ser10-H3), consistent with previous data (Finkin et al,
2008; Wertz et al, 2011). Importantly, when a higher concentration
of paclitaxel (500 nM) was used to better maintain mitotic arrest in
DLD1 FBW7/ cells (Fig EV1C), Mcl-1 degradation occurred as in
wild-type cells (Fig 1B). As observed in HeLa cells, knockdown of
APC11 also stabilised Mcl-1 in mitotically arrested DLD1 WT cells
compared to control knockdown cells (siLuc) (Fig 1C). These results
indicate that Mcl-1 degradation during mitotic arrest is mediated by
the APC/C, whereas loss of Fbw7 causes an apparent stabilisation
of Mcl-1 because of its ability to promote premature exit from mito-
sis rather than by inhibiting Mcl-1 degradation during mitotic arrest.
To analyse rates of protein destruction more accurately and
exclusively in mitotic cells with precise correlation to the timing of
mitosis, we established cell lines expressing inducible YFP-tagged
Mcl-1 and used live-cell imaging of the fluorescent fusion protein to
monitor events in individual mitotic cells. YFP-Mcl-1 was degraded
during mitotic arrest similar to endogenous Mcl-1 (Fig EV1D).
However, compared with some other APC/C substrates, such as
Nek2A and cyclin A, which are degraded rapidly despite an active
checkpoint (Hayes et al, 2006; Di Fiore & Pines, 2010), the rate of
YFP-Mcl-1 degradation was relatively slow (compare Fig 1D with
Fig EV1E), as would be required for an apoptotic timer. Consistent
with our previous results, YFP-Mcl-1 degradation in cells arrested in
mitosis was inhibited by loss of APC/C activity (concomitant knock-
down of the catalytic subunits APC2 and APC11) but was unaffected
by depletion of Fbw7 (Fig 1D), even though the efficiency of knock-
down was sufficient to stabilise protein levels of cyclin E and
c-Myc, both well-documented Fbw7 substrates (Davis et al, 2014;
Fig EV1F). Together, these results confirm that Mcl-1 degradation
during mitotic arrest is not regulated by Fbw7 but is instead directed
by the APC/C.
A putative D box is a determinant of Mcl-1 degradation
We have identified a putative D box motif in Mcl-1, as well as a C-
terminal IR tail, which is also found in the APC/C adaptor/activator
proteins Cdc20 and Cdh1 (Harley et al, 2010; Fig 2A). Immediately
C-terminal to the putative D box, we also noted a region containing
charged residues including putative acceptor lysine residues that
form a loosely defined sequence also found in other APC/C
substrates. This region has been proposed to be a docking site for
UbcH10, the initiating E2 for the APC/C (Williamson et al, 2011;
Chang et al, 2015). Mutation of two key residues in the D box
strongly inhibited YFP-Mcl-1 degradation (Fig 2B), consistent with
our previous Western blotting analysis (Harley et al, 2010). Muta-
tion of charged residues including two lysine residues C-terminal to
the D box also stabilised YFP-Mcl-1, although to a lesser extent than
the D box mutation (Fig 2C). The spacing between the D box and
the lysines contained in this charged region suggests that they may
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Figure 1. Mcl-1 destruction during mitotic arrest is mediated by the APC/C, not SCFFbw7.
A HeLa cells transfected with control (siLuc), APC11 or Fbw7 siRNA for 48 h were synchronised in mitotic arrest with 830 nM nocodazole for 2 and 6 h and samples
analysed with antibodies as indicated. An untreated sample () was used as a control.
B DLD1 FBW7+/+ (WT) and FBW7/ (KO) cells were released from a double thymidine block prior to addition of paclitaxel (500 nM). Samples were collected at times
indicated after thymidine washout.
C DLD1 cells WT for FBW7 transfected with control (siLuc) or APC11 siRNA were treated as in (B).
D HeLa-YFP-Mcl-1 cells were transfected with siRNA as indicated and treated with nocodazole 48 h later. YFP-Mcl-1 fluorescence was monitored from the time of
mitotic entry. Error bars represent SD, n = 3. Scale bar, 10 lm.
Source data are available online for this figure.
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be targeted by UbcH10-APC/C for ubiquitination (Chang et al,
2015). Thus, the partial stabilisation exhibited by this mutant may
be due either to loss of an UbcH10 docking site or loss of the opti-
mal ubiquitin acceptor site(s). Nevertheless, these results attest
further to the identity of the APC/C as an E3 ubiquitin ligase that
targets Mcl-1 during mitotic arrest.
Deletion of the C-terminal IR motif (DIR) had no impact on the
rate of YFP-Mcl-1 loss during mitotic arrest (Fig 2D), in contrast to
Nek2A where a C-terminal methionine-arginine (MR) motif contri-
butes to maximal Nek2A degradation during mitosis (Hayes et al,
2006). However, expression of the Mcl-1 D box mutant stabilised
both cyclin A and cyclin B1 during mitotic arrest, as previously
noted (Harley et al, 2010), and this was also the case for Nek2A
degradation (Fig 2E), suggesting a dominant inhibitory effect on the
APC/C. Remarkably, the ability of the Mcl-1 D box mutant protein
to stabilise other substrates of the APC/C was lost when the IR motif
was also deleted (DboxDIR). Thus, although it is not necessary for
Mcl-1 degradation, the IR motif appears to regulate the manner in
which Mcl-1 engages with the APC/C to the exclusion of other
substrates when the interaction is stabilised.
The IR tail of Mcl-1 influences APC/C subunit requirements
The APC/C is a multisubunit enzyme that is activated by a co-factor,
generally Cdc20 during mitosis and Cdh1 following mitotic exit.
APC2 and APC11 form the catalytic core of APC/C while APC10
together with Cdc20 forms a receptor that recognises and binds to
the D box of the substrate. Cdc20 and Cdh1, like Mcl-1, possess a C-
terminal IR motif through which they bind to the scaffolding
subunit, APC3. This is required for the substrate recruitment func-
tion of Cdc20/Cdh1. Cdc20 also binds to another scaffold subunit,
APC8, to elevate the activity of APC/C (Chang et al, 2014, 2015). To
examine the role of the IR motif in Mcl-1, we investigated the
requirement for individual components of the APC/C in the degra-
dation of wild-type (WT) and IR-deleted (DIR) YFP-Mcl-1 during a
nocodazole arrest. Knockdown of either APC3 or APC11 stabilised
YFP-Mcl-1 (WT Mcl-1; Figs 3A and EV2A). Similarly, YFP-Mcl-1DIR
was stabilised by loss of APC11; however, unlike the wild-type
protein, its degradation was hardly affected by APC3 knockdown
(Figs 3B and EV2A). This suggests that the IR motif of Mcl-1 inter-
acts with APC3 in a manner analogous to the IR tail of Cdc20
(Chang et al, 2014) and as suggested for the MR of Nek2A (Hayes
et al, 2006), thus aiding recruitment of the protein to the APC/C.
Interestingly, depletion of APC8 had no effect on the degradation of
either protein (Fig 3A and B), which is consistent with the lack of
stimulation by Cdc20 under these conditions. In contrast, and as
expected, both cyclin A and cyclin B1 were stabilised by knockdown
of each of the three APC/C subunits tested (Fig EV2B–D).
Interestingly, whereas degradation of WT YFP-Mcl-1 was insensi-
tive, like cyclin A (Izawa & Pines, 2011), to loss of APC10 (Fig 3C),
the degradation of YFP-Mcl-1DIR was retarded to an extent similar
to that observed for cyclin B1 (Figs 3D, and EV2E and F). This
suggests that APC10 is more important for Mcl-1DIR recruitment
because loss of the IR-APC3 module invokes a greater reliance on
the D box-APC10 interaction. Together, the differences in APC/C
subunit requirement between WT Mcl-1 and Mcl-1DIR destruction
indicate that the IR tail alters the nature of the interaction between
Mcl-1 and the APC/C.
The IR tail makes Mcl-1 degradation insensitive to the
mitotic checkpoint
Although deletion of the IR motif had no discernible effect on YFP-
Mcl-1 degradation during a strong mitotic arrest (Fig 2D), it did
affect the rate of degradation upon exit from an unperturbed mitosis
(Fig 4A). Fluorescence intensity declined sharply in YFP-Mcl-1DIR-
expressing cells as they progressed through mitosis and continued
as the cells underwent cytokinesis, whereas YFP-Mcl-1 declined
more slowly and then became stabilised. IR-deleted Mcl-1 was,
therefore, degraded more rapidly and completely than wild-type
Mcl-1 protein when the checkpoint was switched off.
To investigate this further, we analysed the effect on Mcl-1
stability of inhibiting the checkpoint in cells arrested in mitosis by
nocodazole. Under these conditions, the degradation of YFP-Mcl-1
was unaffected when the checkpoint was weakened by the Mps1
kinase inhibitor, reversine (Santaguida et al, 2010). Even in cells
treated with a high dose of reversine, which caused them to exit
mitosis rapidly, Mcl-1 degradation proceeded at a steady rate
(Fig 4B). In stark contrast, the rate of YFP-Mcl-1DIR degradation
increased dramatically as the checkpoint was weakened by increas-
ing concentrations of reversine (Fig 4C). Thus, the APC/C-depen-
dent degradation of Mcl-1 during mitosis is held in check by the IR
tail. Without the interaction of the IR tail with the APC/C, Mcl-1
undergoes very rapid degradation when the checkpoint is switched
off.
The IR tail converts Mcl-1 from a Cdc20-dependent substrate to
one that is degraded relatively slowly and independently of
checkpoint control
Our finding that Mcl-1 degradation is unaffected by the spindle
assembly checkpoint is unusual for an APC/C substrate, since the
rates of loss of even those substrates such as cyclin A that are
rapidly degraded by a Cdc20-dependent mechanism during mitotic
arrest are still influenced by the checkpoint (Collin et al, 2013). We
found that when Cdc20 was efficiently depleted by siRNA-mediated
knockdown (Fig EV3A and B), YFP-Mcl-1 degradation and ubiquiti-
nation were not inhibited (WT Mcl-1; Figs 5A and EV3C). Rather
there was a slight acceleration of YFP-Mcl-1 degradation when
Cdc20 was removed. These results are in contrast to our previous
biochemical experiments in which Cdc20 was depleted, albeit ineffi-
ciently (Harley et al, 2010), but in agreement with the lack of stabil-
isation of Mcl-1 following Cdc20 knockdown observed by others
(Dı´az-Martı´nez et al, 2014; Sloss et al, 2016). Indeed, we did not
observe a requirement for an APC/C co-factor for Mcl-1 degradation
since even efficient co-depletion of both Cdc20 and Cdh1 failed to
inhibit the loss of YFP-Mcl-1 during mitotic arrest (Fig EV3D). In
contrast, concurrent knockdown of APC2 and APC11 both
prevented YFP-Mcl-1 ubiquitination (Fig EV3C) and stabilised the
protein (Fig 1D). Similarly, under stringent checkpoint conditions,
YFP-Mcl-1DIR degradation was also unaffected by knockdown of
Cdc20 (Figs 5B and EV3E), despite the reduction in Cdc20 being suf-
ficient to stabilise cyclin A (Fig EV3F).
Remarkably, however, the rapid degradation of YFP-Mcl-1DIR
that occurred when the checkpoint was weakened was dependent
upon Cdc20 such that prior Cdc20 knockdown slowed YFP-Mcl-
1DIR degradation to a rate comparable to that of YFP-Mcl-1
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Figure 2. The C-terminal IR motif is dispensable for Mcl-1 degradation.
A Sequence alignment of D box and IR motifs in Mcl-1 and other APC/C substrates. Key residues are indicated in the D box (blue) and C-terminal to the D box (red);
those mutated in this study are underlined. The IR motif at the C-terminus is highlighted (italics).
B–D Degradation of WT YFP-Mcl-1 protein compared with a D box mutant (B), charged residue mutant (C) and IR-deleted (DIR) Mcl-1 proteins (D) during mitotic arrest
by time-lapse imaging. Error bars represent SD, n = 3. Scale bar, 10 lm.
E U2OS cells expressing Flag-tagged WT, D box mutant or D box mutant DIR Mcl-1 proteins were synchronised in mitotic arrest with paclitaxel (100 nM). Samples
were collected at times indicated and blotted with antibodies as shown.
Source data are available online for this figure.
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Figure 3. The IR tail alters APC/C subunit requirements for Mcl-1 degradation.
A, B APC3, APC8 or APC11 were knocked down by siRNA prior to treatment with nocodazole to induce mitotic arrest. The effect on the degradation of YFP-Mcl-1 WT (A)
and DIR (B) protein was analysed by time-lapse microscopy. Representative images (left) and quantification (right) are shown. Error bars represent SD, n = 3.
Scale bar, 10 lm.
C, D The effect of knocking down APC10 on YFP-Mcl-1WT (C) and DIR (D) proteins during mitotic arrest is shown as for (A, B). Error bars represent SD, n = 3. Scale bar,
10 lm.
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Figure 4. The IR tail renders Mcl-1 degradation insensitive to the mitotic checkpoint.
A Representative images (left panels) and quantification (right panels) of the degradation of YFP-Mcl-1 WT and DIR proteins in unperturbed mitosis. Fluorescence
(upper panels) and transmitted light (lower panels) images are shown. Scale bar, 10 lm.
B, C Representative images (left panels) and quantification (right panels) of the degradation of YFP-Mcl-1 WT (B) and DIR (C) in cells entering mitosis in the presence of
nocodazole and indicated concentration of reversine. In (B), mean values at each time point obtained from three experiments are shown. Error bars represent SD.
In (C), quantification of 10 individual cells from one representative experiment is shown (right). The traces are overlaid with mean values SD (open characters,
n = 3). Scale bar, 10 lm.
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(Fig 5C). The rapid loss of YFP-Mcl-1DIR when the checkpoint
was compromised was also dependent on APC3 (Fig EV3G). The
effect of knocking down Cdc20 was not due simply to its ability
to block mitotic exit, since YFP-Mcl-1DIR degradation continued
even after mitotic exit induced by the CDK1 inhibitor RO-3306
(Vassilev et al, 2006) in control knockdown cells, whereas degra-
dation was inhibited by Cdc20 depletion using siRNA (Fig EV3H).
These results indicate a conventional mode of APC/C-mediated
and Cdc20-dependent degradation of Mcl-1DIR when the check-
point is switched off in which Cdc20 binds to APC3 and recruits
Mcl-1DIR to the APC/C for ubiquitination.
One prediction from these results is that, under weak check-
point conditions, cells expressing Mcl-1DIR would undergo
apoptosis more readily because of the more rapid loss of anti-
apoptotic activity. We specifically knocked down endogenous Mcl-
1 using an siRNA duplex that targets the 30 untranslated region
(UTR), replaced it with either WT Mcl-1 or Mcl-1DIR expressed as
fusions with YFP (Fig EV3I) and then arrested cells with a low
concentration of nocodazole (33 nM). This resulted in rapid degra-
dation of YFP-Mcl-1DIR (Fig 5D), whereas the rate of YFP-Mcl-1
(WT Mcl-1) destruction remained as slow as with a high nocoda-
zole concentration (830 nM; compare Fig 5D with Fig 1D). Under
such weak checkpoint conditions, < 20% WT Mcl-1 cells died. In
marked contrast, almost half (47%) Mcl-1DIR-expressing cells
underwent apoptosis (Fig 5E). This demonstrates that when the
checkpoint is weak and Mcl-1 is degraded rapidly because of the
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absence of the IR motif, extensive cell death is induced, whereas
more stable wild-type Mcl-1 is still largely able to protect cells.
The nature of the mitotic arrest determines cell fate
To explore further the relationship between Cdc20 and Mcl-1 degra-
dation, we utilised proTAME, a cell-permeable molecule that is
processed intracellularly to TAME (tosyl-L-arginine methyl ester),
which mimics an IR dipeptide and binds to APC3, precluding the
interaction of Cdc20 with the APC/C through its IR tail. This binding
prevents the recruitment of Cdc20-dependent substrates to the APC/
C and inhibits APC/C function, thereby arresting cells in mitosis
(Zeng et al, 2010). We found that in cells held in mitosis after treat-
ment with proTAME, YFP-Mcl-1 degradation was similar to that
observed in cells arrested in mitosis by nocodazole (Fig 6A). This
result is in agreement with Sloss et al (2016), who found that apcin,
another reagent that inhibits the stimulation of the APC/C by Cdc20
(Zeng et al, 2010; Sackton et al, 2014), did not block Mcl-1 destruc-
tion. Nevertheless, YFP-Mcl-1 was stabilised in cells arrested by
knockdown of APC2 and APC11, consistent with our previous
observations in the presence of nocodazole (compare Fig 6A with
Fig 1D). Together, these results are consistent with APC/C-mediated
Mcl-1 destruction during mitotic arrest being either independent of
Cdc20 or unusually sensitive to very low levels of the APC/C co-
activator. However, the inability of proTAME to inhibit YFP-Mcl-1
loss even when combined with Cdc20 depletion (Fig EV4A) favours
the conclusion that APC/C-dependent Mcl-1 degradation during
mitotic arrest does not require the stimulation of the APC/C by
Cdc20.
In contrast to YFP-Mcl-1, degradation of cyclin B1-Venus was
negligible during an arrest induced with either proTAME or deple-
tion of APC2 and 11 (Fig 6B). These results demonstrate that two
distinct modes of inducing mitotic arrest have differential effects
on the relative rates of cyclin B and Mcl-1, yielding populations of
cells with different relative levels of these two proteins. Given that
the outcome of a mitotic arrest is likely to be co-ordinately regu-
lated by apoptotic and mitotic thresholds (Gascoigne & Taylor,
2008; Clarke & Allan, 2009), this raises the intriguing possibility
that the nature of a mitotic arrest may influence cell fate. To inves-
tigate this, we compared cell fate profiles of RPE-1 cells arrested
either with proTAME or by concomitant knockdown of APC2 and
11 (Fig EV4B). Under these conditions, the duration of mitotic
delay was similar, negating the influence of time in mitosis on cell
fate (Fig 6C). Analysis was restricted to cells showing a sustained
arrest (≥ 6 h). Consistent with previous results using HeLa cells
(Zeng et al, 2010; Lara-Gonzalez & Taylor, 2012), RPE-1 cells
arrested with proTAME predominantly underwent mitotic cell
death (80%) after arresting for an average of 24 h, while the
remaining 20% slipped out of mitosis after an average arrest of
32 h (Fig 6C, top left panel). In comparison, knockdown of APC2
and APC11 substantially altered the cell fate profile with nearly
30% of cells exhibiting a sustained mitotic arrest (average 41 h)
while some were still arrested at the end of imaging (Fig 6C, top
right panel). Indeed, even those cells that did undergo mitotic cell
death did so after a more prolonged arrest (average 29 h). Notably,
this prolonged cell survival was dependent upon Mcl-1 since
knockdown of Mcl-1 converted the cell fate profile exclusively to
mitotic cell death with an average arrest time prior to death of
19 h (Fig 6C, bottom right panel). Similarly, prior Mcl-1 depletion
further promoted mitotic cell death in response to proTAME
(Fig 6C, bottom left panel). These results suggest that the degrada-
tion of Mcl-1 during a proTAME-induced arrest promotes mitotic
cell death, whereas the relative stability of Mcl-1 following deple-
tion of APC2 and APC11 supports cell survival. Thus, the nature of
the mitotic arrest determines cell fate, at least in part, through its
effect on Mcl-1 protein levels.
Discussion
We have confirmed that, during mitotic arrest, the degradation of
Mcl-1 is directed primarily by the APC/C, an ubiquitin E3 ligase that
regulates many of the proteins involved in mitotic progression. Util-
ising the same experimental systems as reported previously (Wertz
et al, 2011), we have demonstrated that SCFFbw7 does not influence
Mcl-1 protein levels in cells during mitotic arrest. However, loss of
Fbw7 does affect the ability of cells to arrest in mitosis (Finkin et al,
2008; Wertz et al, 2011; this study) and thus may appear to stabi-
lise Mcl-1 in a biochemical analysis unless cells slipping out of
mitosis are excluded. SCFFbw7 might nevertheless play a role in
Mcl-1 degradation after slippage into interphase and thereby influ-
ence subsequent cell fate (Inuzuka et al, 2011; Wertz et al, 2011).
Other E3 ubiquitin ligases, namely Mule/ARF-BP1/HUWE (Zhong
et al, 2005; Shi et al, 2011) and SCFßTRCP (Ding et al, 2007), have
been reported to mediate the degradation of Mcl-1 during inter-
phase. Degradation of a mutant lacking lysine ubiquitin acceptors
has suggested that E3 ligase-independent degradation can also
occur (Sloss et al, 2016). Our results, however, demonstrate that
APC/C-mediated degradation is the major mechanism controlling
Mcl-1 loss during mitosis.
The degradation of Mcl-1 over a period of several hours fulfils
the requirements of an apoptotic timer during mitotic arrest. The
APC/C dependency of Mcl-1 destruction couples the initiation of
its loss to entry into mitosis. Unusually for an APC/C substrate,
however, the mitotic destruction of Mcl-1 is not influenced by
either checkpoint status or known co-factors that enhance APC/C
activity, resulting in a steady loss of Mcl-1 protein that ceases only
when the cell exits mitosis. We propose that the relatively slow
rate of Mcl-1 destruction is determined by an atypical mechanism
of recognition by the APC/C such that the complex is insensitive to
stimulation by Cdc20 and the degradation of Mcl-1 is not induced
like that of cyclin B1 when the checkpoint is relieved. Otherwise,
rapid degradation of Mcl-1 when the checkpoint is weakened or
switched off would result in catastrophic loss of Mcl-1 and apopto-
sis (Fig 7A, left). Under weak checkpoint conditions, as occur
during the normal progression of prometaphase/metaphase when
the checkpoint is maintained for a short period by perhaps only
one or two unattached kinetochores (Rieder et al, 1995; Collin
et al, 2013), the limited destruction of wild-type Mcl-1 that occurs
prior to mitotic exit would not compromise cell viability (Fig 7A,
middle). Under conditions of a prolonged, strong checkpoint arrest
when mitosis is dramatically disrupted by a failure to form the
mitotic spindle, for instance due to the action of a cancer
chemotherapeutic microtubule poison, the steady rate of Mcl-1
destruction would still result in apoptosis once a threshold level
was reached because its degradation is insensitive to the
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checkpoint even though the rate of degradation of cyclin B1 and
other mitotic APC/C substrates that hold a cell in mitosis
is reduced (Fig 7A, right). Thus, the atypical mechanism of APC/
C-dependent Mcl-1 destruction ensures that the initiation of apop-
tosis during mitotic arrest is dependent on the period of mitosis
and not the degree of checkpoint activation.
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Figure 6. The mode of mitotic arrest alters Mcl-1 destruction and determines cell fate.
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Taken together, the checkpoint insensitivity of Mcl-1 degrada-
tion, the lack of dependency on APC8 and the lack of inhibition by
an efficient knockdown of Cdc20 and/or treatment with TAME all
indicate that Mcl-1 is usually ubiquitinated during mitotic arrest by
the APC/C unstimulated by Cdc20. The contrasting rapid, Cdc20-
dependent degradation of Mcl-1DIR when the checkpoint is released
argues against the alternative explanation that Mcl-1 recognition by
the APC/C requires only a trace of Cdc20. Rather, it appears that
stimulation by Cdc20 of APC/C activity towards Mcl-1 is usually
prevented by the competing interaction of the IR tail of Mcl-1 with
the APC/C, but in the absence of this interaction, Mcl-1 behaves as
a conventional APC/CCdc20 substrate. Despite its usual lack of
dependency on Cdc20, Mcl-1 degradation is, however, still depen-
dent on its D box motif, which suggests that the D box is required
for correct alignment of Mcl-1 with the APC/C even in the absence
of the co-factor or it plays a role in the release of the substrate from
the enzyme. Indeed, the dominant inhibitory effect of the D box
mutant of Mcl-1 on the degradation of other APC/C substrates
suggests that this mutant forms a more stable interaction with the
APC/C than the wild-type protein.
The unusual mode of functional interaction of Mcl-1 with the
APC/C may provide a mechanism for regulation of Mcl-1 degra-
dation during mitosis. For instance, phosphorylation of Mcl-1 by
Cdk1-cyclin B, which promotes Mcl-1 degradation (Harley et al,
2010), might affect the interaction of the IR tail with the APC/C,
thereby promoting Mcl-1 degradation through a Cdc20-stimulated
mechanism. This could occur when CDK1-cyclin B activity is high
but the spindle assembly checkpoint is weak. Such conditions
might explain why we previously observed a dependency of
Mcl-1 loss on Cdc20 in experiments in which Cdc20 depletion
was partial and the cells were prone to slippage from mitosis
(Harley et al, 2010). The binding of a partner protein such as
Noxa could also affect the interaction of Mcl-1 with the APC/C
and control Mcl-1 stability (Nakajima et al, 2014; Haschka et al,
2015). Conversely, although the interaction of the APC/C with
Mcl-1 is likely to be normally sufficiently transient to not interfere
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with the recognition of other substrates such as cyclin B, there is
the potential for this interaction to significantly affect APC/C
function when its activity is limited or when Mcl-1 is highly
expressed, for instance in certain cancer cells. Indeed, depletion
or over-expression of Mcl-1 has been reported to affect cyclin B1
destruction and the timing of exit from mitosis (Sloss et al,
2016). Thus, Mcl-1 might play an indirect role in influencing
progression through mitosis as well as the onset of mitotic cell
death.
We have demonstrated that the atypical mode of Mcl-1 degrada-
tion during mitosis can be exploited to influence cell fate. Utilising
proTAME to arrest cells in mitosis while still permitting Mcl-1
destruction promotes cell death. In contrast, a strategy of targeting
the APC/C directly stabilises Mcl-1 during the arrest and supports
cell survival (Fig 7B). Previously, it has been shown that the dura-
tion of the mitotic arrest correlates with the likelihood that a cell
will undergo apoptosis (Bekier et al, 2009; Huang et al, 2009;
Colin et al, 2015). Furthermore, targeting Cdc20 was suggested as
more efficient than spindle poisons at inducing apoptosis because
it blocked mitotic exit in slippage-prone cells (Huang et al, 2009).
Our data now provide an explanation for these effects. Cdc20 loss
does not simply prevent slippage and increase the time spent in
mitotic arrest; crucially, cells arrested in this way continue to
degrade Mcl-1. As a result, the apoptosis threshold is overcome
while cells are still arrested in mitosis (Fig 7B). Thus, cell fate is
determined by the nature as well as the duration of mitotic arrest.
Inhibiting Cdc20, therefore, offers a therapeutic opportunity to
specifically target Mcl-1 for destruction and engage the apoptotic
machinery during a protracted mitosis. Conversely, Mcl-1 would
be stabilised and apoptosis inhibited by a strategy targeting the
APC/C directly, which might have less desirable consequences for
cancer chemotherapy.
If TAME inhibits the interaction of the IR tail of Mcl-1 with
the APC/C, concurrent interference with the stimulation of the
APC/C by Cdc20 is presumably the reason that TAME does not
accelerate Mcl-1 destruction during mitosis. Therefore, an
improved strategy might be to design a selective inhibitor of the
interaction between the C-terminal tail of Mcl-1 and the APC/C,
which would mimic the IR deletion and accelerate the Cdc20-
dependent degradation of Mcl-1 to actively promote death in
cells arrested in mitosis by combination with a microtubule
poison or other anti-mitotic drug.
Materials and Methods
Antibodies and reagents
The following antibodies were used for Western blotting: APC11 (1/
500, ab57158) and MYC (1/5,000, ab32072), Abcam; APC3 (1/
1,000, 610454), cyclin A (1/1,000, 611269), Mcl-1 (1/500, 559027)
and Nek2A (1/500, 610593), BD Transduction Laboratories; APC8
(1/1,000, A301-181A) and Fbw7 (A301-720A-1), Bethyl Laborato-
ries; APC2 (1/1,000, 12301S) and cyclin E (1/1,000, 4129S), Cell
Signaling Technologies; MPM2 (1/1,000, 05-368), Millipore; APC10
(1/1,000, sc-166790), Cdc20 (1/1,000, sc-13162) and cyclin B1 (1/
2,000, sc-752), Santa Cruz Biotechnology; Actin (1/4,000, A2066)
and Mad2 (1/1,000, PA5-21594), Sigma Aldrich; Cdh1 (1/500,
MS1116-P0), Thermofisher. Antibodies were used according to
standard protocols except for Fbw7 where blocking and primary
antibody incubation were carried out in ReliaBLOT (Bethyl
Laboratories). Histone H3 phospho-Ser10 (05-806), Millipore, was
used for flow cytometry as described previously (Harley et al,
2010). Fbw7 (A301-721A-1), Bethyl Laboratories, was used for
immunoprecipitation. Doxycycline, thymidine, paclitaxel and rever-
sine were purchased from Sigma Aldrich. Nocodazole (Calbiochem)
was routinely used at 830 nM apart from assaying cyclin B1 degra-
dation where it was used at 33 nM. ProTAME was initially provided
by Dr Randall King (Dept. of Cell Biology, Harvard University) and
subsequently purchased from Boston Biochem.
Cell lines and treatments
Authenticated HeLa (OHIO) and U2OS (HTB96) were obtained from
Cell Services, Cancer Research UK London Research Institute, RPE-1
cells were from ATCC, and DLD1 parental and FBW7/ cells (Wertz
et al, 2011) were purchased from Horizon Discovery Ltd. HeLa Flp-
In cells (Tighe et al, 2008) stably expressing a TetR were from Prof
Stephen Taylor (Manchester). All cells were cultured in DMEM, 10%
FBS, 2 mM L-glutamine and 50 lg/ml penicillin/streptomycin. Cells
were routinely tested for mycoplasma contamination. The generation
of U2OS cells expressing Flag-Mcl-1 WT or Flag-Mcl-1 D box mutant
was described previously (Harley et al, 2010). U2OS Flag-Mcl-1 D
box mutant DIR cells expressing Mcl-1 R207A/L210A/C-terminal 2
amino acids (IR) deleted were generated in the same way. Flp-In
cells stably expressing a doxycycline-inducible construct were gener-
ated by co-transfection of pOG44 (Invitrogen) and cDNAs cloned into
pc5-LAP-YFP or pc5-LAP-Venus. Stable polyclonal cell lines were
selected in media supplemented with Hygromycin (200 lg/ml).
Doxycycline (1 lg/ml) was added to inducible cell lines for 8 h to
induce protein expression prior to imaging. The protocol for
synchronising cells in the period of mitotic arrest with nocodazole
was described previously (Harley et al, 2010). For synchronisation
of DLD1 cells, thymidine (2 mM) was added for 16 h followed by
incubation in thymidine-free media for 8 h prior to incubation with
thymidine for a further 16 h. Cells were then released into normal
media for 6 h prior to addition of paclitaxel to arrest cells in mitosis.
Vectors
For Mcl-1 constructs to generate inducible cell lines, AgeI (50) and
ApaI (30) restriction sites were introduced by PCR using WT or D
box or DIR mutant Flag-Mcl-1 vectors as templates. The resulting
Mcl-1 cDNA was used to replace Mps1 in pc5-LAP-YFP-Mps1
(Nijenhuis et al, 2013) C-terminal to YFP. The YFP-Mcl-1 charge
mutant R233A/K234A/D236A/K238A/E240A was generated by site-
directed mutagenesis using pc5-LAP-YFP-WT Mcl-1 as a template.
Nek2A was amplified by RT–PCR and cloned into pc5-LAP-YFP
vector as for Mcl-1. To generate pc5-cyclin A-Venus, cyclin A-Venus
was isolated from pc4-cyclin A-Venus using HindIII and ApaI and
used to replace cyclin B1-mCherry in pc5. To generate pc5-cyclin
B1-Venus, Venus cDNA was isolated from pc4-cyclin A-Venus using
BamHI and ApaI. This was used to replace mCherry in pc5-cyclin
B1-mCherry. Cyclin constructs were provided by Dr Adrian Saurin
(Dundee). pMT.107-(His6Ub)8 was provided by Dr David Meek
(Dundee).
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Transfections
To generate stable inducible cell lines, vectors were co-transfected
with pOG44 (encodes a FLP recombinase) into HeLa Flp-In cells
stably expressing a TetR using FuGene HD according to the manu-
facturer’s instructions (Promega). To knockdown protein expres-
sion, ON-TARGETplus siRNAs from Dharmacon were used unless
otherwise stated: Fbw7-1 GGGCACCAGUCGUUAACAA (J-004264-
07), Fbw7-3 GGAGUUGUGUGGCGGAUCA (J-004264-09) and Fbw7-
4 CAACAACGACGCCGAAUUA (J-004264-10); APC2-2 GAUCGUAU
CUACAAC AUGC (J-003200-12), APC2-3 GACAUCAUCACCCUCUAU
(J-003200-11) and APC2-4 GAGAUGAUCCAGCGUCUGU (J-003200-
10); APC3-1 GGAAAUAGCCGAGAGGUAA (J-003229-11) and APC3-
2 CAAAAGAGCCUUAGUUUAA (J-003229-12); APC8-1 GAAAUUAA
AUCCUCGGUAUUU and APC8-2 GCAGUUGCCUAUCACAAUAUU
(Izawa & Pines, 2011; Eurofins-MWG); APC10-1 GAGCUCCA
UUGGUAAAUUUUU and APC10-2 GAAAUUGGGUCACAAGCUGUU
(Izawa & Pines, 2011; Eurofins-MWG); APC11-1 (UCUGCAGG
AUGGCAUUUAA and APC11-2 AAGAUUAAGUGCUGGAACG
(Mansfeld et al, 2011; Eurofins-MWG); Cdc20-1 CGGAAGAC
CUGCCGUUACA (J-003225-14), Cdc20-2 GGGCCGAACUCCUGG
CAAA (J-003225-15), Cdc20-3 GAUCAAAGAGGGCAACUAC
(J-003225-16) and Cdc20-4 CAGAACAGACUGAAAGUAC (J-003225-
17); Cdh1 50-AAU GAG AAG UCU CCC AGU CAG-30 (Bashir et al,
2004); Mcl-1 UTR CGAAGGAAGUAUCGAAUUU (J-004501-17);
GAPDH AUUCCAUGGCACCGUCAAG and Luciferase GL2 CGUAC
GCGGAAUACUUCGA (Eurofins-MWG). siRNA duplexes for each
target were pooled and transfections carried out using 10–20 nM
final duplex concentration and LipofectAmine RNAiMAX (Invitro-
gen) according to the manufacturer’s instructions for 48 h apart
from for Cdc20 which was carried out for 24 h.
Live-cell imaging
To study fluorescent protein stability by time-lapse analysis, cells
were plated into eight-well chamber slides (Ibidi). For knockdown
experiments, cells were treated for 24 h with thymidine (2 mM)
before being released into Leibovitz L-15 medium (Sigma), supple-
mented with 10% FBS, 2 mM L-glutamine, 100 lg/ml penicillin/
streptomycin and 1 lg/ml doxycycline. For other experiments, plat-
ing media was replaced with L-15 and doxycycline as above. After
4 h, nocodazole was added and, a further 4 h later, cells were
imaged in a heated chamber (37°C), using Delta Vision Core or Elite
microscope system equipped with a 40×/1.30 NA U Plan FLN objec-
tive using softWoRx software. Images were acquired with a Cool-
SNAP HQ2 camera (Photometrics) and processed using softWoRx
software and ImageJ Fiji. Stacks of five images at 6-lm intervals
were taken at 4 min intervals for 16–18 h. Maximum intensity
projection of the fluorescent channels was performed using soft-
WoRx software. In all experiments assessing unperturbed mitosis or
mitosis with a weak spindle assembly checkpoint, a brightfield refer-
ence image was also captured to visualise cell morphology. Images
shown were selected to most closely represent the mean data. For
analysis of cell fate, cells were cultured in 24-well plates (Thermo
Scientific) in DMEM supplemented with 10% (v/v) foetal bovine
serum and 1% (v/v) penicillin-streptomycin (Invitrogen). Cells were
imaged every 10 min in a heated chamber (37°C, 5% CO2) using an
EC Plan-Neofluar 10×/0.3 objective on a Zeiss Axiovert 200M
microscope. Images were acquired using a C4742-80-12AG camera
(Hamamatsu) and lmanager software and were processed using
ImageJ Fiji. Cell death was defined by morphology and cessation of
cell movement. For the determination of cell fate in RPE cells, analy-
sis was carried out on cells that were arrested in mitosis for at least
6 h.
Analysis of Mcl-1 ubiquitination
YFP-Mcl-1 cells were transfected with siRNA against APC2 and
APC11 (48 h) or Cdc20 (24 h) and with pMT.107-(His6Ub)8 or
control vector. Dox was added to induce expression of YFP-Mcl-1
for 18 h prior to addition of nocodazole (0.83 lM) and MG132
(10 lM) for 4 h. Mitotic cells were isolated and divided into two as
follows: for input samples, cells were lysed in SDS loading buffer
(50 mM Tris, pH 6.8; 2% SDS; 10% glycerol) and the protein
concentration was determined; for pulldowns, cells were lysed in
guanidine-HCl buffer (6 M guanidine-HCl; 10 mM Tris, pH 8.0;
0.1 M Na2HPO4; 5 mM imidazole) with the volume dictated by the
concentration of the input samples. Lysates were sonicated and
incubated with nickel-NTA agarose beads at room temperature for
4 h. Pulldowns were washed with urea wash buffer (8 M urea;
0.1 M Na2HPO4) sequentially containing A (0.1% Triton X-100;
10 mM Tris, pH 8.0), B (0.2% Triton X-100; 10 mM Tris, pH 6.5)
and C (0.1% Triton X-100; 10 mM Tris, pH 6.5). Proteins were
eluted in elution buffer (250 mM imidazole; 5% 2-mercaptoethanol;
50 mM Tris, pH 6.8; 2% SDS; 10% glycerol).
Expanded View for this article is available online.
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